Resultados da pesquisa - Martin Nuttall

A Phase II study of neoadjuvant axitinib for reducing the extent of venous tumour thrombus in clear cell renal cell cancer with venous invasion (NAXIVA) Por Grant D. Stewart, Sarah J. Welsh, Stephan Ursprung, Ferdia A. Gallagher, James O. Jones, Jacqui Shields, Christopher G. Smith, Thomas J. Mitchell, Anne Y. Warren, Axel Bex, Ekaterini Boleti, Jade Carruthers, Tim Eisen, Kate Fife, Abdel Hamid, A. Douglas Laird, Steve Leung, Jahangeer Malik, Iosif Mendichovszky, Faiz Mumtaz, Grenville Oades, Andrew N. Priest, Antony C.P. Riddick, Balaji Venugopal, Michelle Welsh, Kathleen Riddle, Lisa Hopcroft, Niki Couper, Lisa Hopcroft, Robert Hill, Athena Matakidou, Cara Caasi, James Watson, Lauren Wallis, Ruby Cross, Sarah Burge, Anne George, Tobias Klatte, Tevita Aho, James N. Armitage, Sabrina Rossi, Charles Massie, Shubha Anand, Tiffany Eira Haddow, Marc Dodd, Wenhan Deng, José-Ezequiel Martín, Philip Howden, Stephanie Wenlock, Evis Sala, Stefan N. Symeonides, Lynn Ho, Jennifer Baxter, Stuart W. Leslie, Duncan McLaren, John E. Brush, Marie O’Donnell, Alisa Griffin, Ruth Orr, Catriona Cowan, Thomas Powles, Anna Pejnovic, Sophia Tincey, Lee Alexander Grant, Martin Nuttall, Lucy Willsher, Christian Barnett, David Nicol, James Larkin, Alison Fielding, Robert J. Jones